Ascendis Pharma
ASND
ASND
65 hedge funds and large institutions have $1.22B invested in Ascendis Pharma in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 58 → 65 (+7)
4.41% less ownership
Funds ownership: 88.3% → 83.9% (-4.4%)
Holders
65
Holding in Top 10
12
Calls
–
Puts
–
Top Buyers
| 1 | +$18.2M | |
| 2 | +$17.3M | |
| 3 | +$12M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$10.8M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$5.13M |
Top Sellers
| 1 | -$9.15M | |
| 2 | -$7.45M | |
| 3 | -$7.16M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.6M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$3.53M |